TIDMAVG

RNS Number : 0227D

Avingtrans PLC

01 July 2016

Avingtrans Plc

("Avingtrans" or the "Company" or the "Group")

Exercise of Share Options

Avingtrans (AIM:AVG), a manufacturer of critical components and associated services to the global aerospace, energy and medical sectors announces that on 1 July 2016 the Company was notified of the exercise of 60,267 options over ordinary shares of 5p each in the Company ("Ordinary Shares") to certain directors, of which 60,000 options have an exercise price of 96 pence and 267 options have an exercise price of 39.5 pence.

Details of the exercise of options by certain directors of the Company and the subsequent beneficial holdings of such directors following these transactions is set out below:

 
 Director             Number of Options   Number of Options     Beneficial interest 
                       exercised at 96p    exercised at 39.5p    in Ordinary Shares 
                                                                 after the transaction 
 
 Stephen McQuillan    30,000              -                     360,566 
 Stephen King         30,000              267                   316,338

Pursuant to the above transactions, Avingtrans announces that 60,267 ordinary shares of 5p each in the Company have been allotted. Application has been made to the London Stock Exchange for the new ordinary shares to be admitted to trading on AIM and it is expected that admission will take place on 7 July 2016. The new ordinary shares will rank pari passu with the existing shares of the Company.

After admission of these new shares, the Company's total issued share capital is 27,814,831 Ordinary Shares. Avingtrans does not hold any Ordinary Shares in treasury. Therefore, the total number of voting rights in Avingtrans is 27,814,831.

The above figure 27,814,831 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Avingtrans under the FSA's Disclosure and Transparency Rules.

Enquiries:

 
 Avingtrans plc 
  Steve McQuillan, CEO 
  Stephen King, CFO                    0115 949 9020 
 Numis Securities Limited 
  Tom Ballard (Corporate Broking) 
  Richard Thomas (Corporate Finance 
  and Nominated Adviser)               020 7260 1000 
 Newgate 
  (Financial PR) 
  Adam Lloyd 
  Ed Treadwell                         020 7653 9850

About Avingtrans

 
 
Avingtrans plc is engaged in the provision of highly engineered 
 components, systems and services to the energy, medical 
 and traffic management industries worldwide. 
 
 
 
  Energy and medical, engaged in the design and manufacture 
   of safety critical equipment for the energy, medical, science 
   and research communities, including oil and gas extraction 
   and processing equipment, nuclear process plant, machined 
   and fabricated pressure and vacuum vessels and components. 
   Also, design and manufacture of fabricated poles and cabinets 
   for roadside safety cameras and rail track signalling. 
   The strategy of the group, is to "buy and build" in regulated 
   engineering niche markets, where we can see potential consolidation 
   opportunities, which can lead to significantly increased 
   shareholder value over the medium to long term.

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHEADXFEFXKEFF

(END) Dow Jones Newswires

July 01, 2016 09:18 ET (13:18 GMT)

Avingtrans (LSE:AVG)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Avingtrans Charts.
Avingtrans (LSE:AVG)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Avingtrans Charts.